Oncternal Therapeutics, Inc. (NASDAQ:ONCT) Given Consensus Recommendation of Hold by Analysts

Shares of Oncternal Therapeutics, Inc. (NASDAQ:ONCT – Get Free Report) have been given a consensus recommendation of “Hold” by the six ratings firms that are presently covering the firm, Marketbeat reports. Four investment analysts have rated the stock with a hold recommendation and two have given a buy recommendation to the company. The average twelve-month […]

Related Keywords

,Oncternal Therapeutics Inc ,Nasdaq ,Vanguard Group Inc ,Oncternal Therapeutics Company Profile ,Renaissance Technologies ,Millennium Management ,Pasadena Private Wealth ,Healthcare Of Ontario Pension Plan Trust Fund ,Oncternal Therapeutics ,Get Free Report ,Capital Management ,Therapeutics Stock Down ,Ontario Pension Plan Trust Fund ,Get Free ,Orphan Receptor ,Oncternal Therapeutics Daily ,